ROLKE JAMES (Chief Executive Officer) received a stock award from REVELATION BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/12/2026ACC: 0001193125-26-010648
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+532.83K
Net shares
Net buyer
$479.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
532.83K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+532.83K
Price / share
$0.90
Trade value
$479.55K
% of position
133.0%
1/8/2026
400.66K→933.49K
Total
Net shares
+532.83K
Net value
$479.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2026 | A · Award | +532.83K | $0.90 | $479.55K | 133.0% | 400.66K | 933.49K |
| Total | +532.83K | $479.55K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned400.66K
Total
400.66K direct400.66K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 400.66K | Direct |
| Total | 400.66K | 400.66K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported